Discontinued — last reported Q4 '25
Year-over-year, this metric declined by 100.0%, from $141.00M to $0.00.
Higher values suggest more aggressive M&A activity with performance-based earn-outs, potentially indicating higher integration risk.
Reflects the fair value of contingent consideration liabilities assumed as part of business combinations, where future p...
Common in industries with frequent M&A activity, such as hospitality, technology, and pharmaceuticals.
supplemental_noncash_or_part_noncash_acquisition_conting_f77def| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $107.00M | $0.00 | $0.00 | $0.00 | $141.00M | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | -100.0% | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | — | — | — | — | — | — | -100.0% |